PM2 EFFECTS OF PRIMARY PROPHYLACTIC G-CSF USE AND DURATION OF USE ON NEUTROPENIA HOSPITALIZATIONS FOR ELDERLY BREAST CANCER PATIENTS RECEIVING CHEMOTHERAPY
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72037-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)72037-4/fulltext
Section Title :
Section Order :
117
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72037-4&doi=10.1016/S1098-3015(10)72037-4